Abstract
Glycosaminoglycans like heparin and heparan sulfate exhibit a high degree of structural microheterogeneity. This structural heterogeneity results from the biosynthetic process that produces these linear polysaccharides in cells and tissues. Heparin and heparan sulfate play critical roles in normal physiology and pathophysiology, hence it is important to understand how their structural features may influence overall activity. Therefore, high-resolution techniques like mass spectrometry represent a key part of the suite of methodologies available to probe the fine structural details of heparin and heparan sulfate. This chapter outlines the application of techniques like LC-MS and LC-MS/MS to study the composition of these polysaccharides, and techniques like GPC-MS that allow for an analysis of oligosaccharide fragments in these mixtures.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Carlsson P, Kjellén L (2012) Heparin biosynthesis. Handbook Exp Pharmacol 207:23–41
Capila I, Linhardt RJ (2002) Heparin-protein interactions. Angew Chem 41(3):390–412
Bishop JR, Schuksz M, Esko JD (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446(7139):1030–1037
Kailemia MJ, Li L, Xu Y, Liu J, Linhardt RJ, Amster IJ (2013) Structurally informative tandem mass spectrometry of highly sulfated natural and chemoenzymatically synthesized heparin and heparan sulfate glycosaminoglycans. Mol Cell Proteomics 12(4):979–990
Naggar EF, Costello CE, Zaia J (2004) Competing fragmentation processes in tandem mass spectra of heparin-like glycosaminoglycans. J Am Soc Mass Spectrom 15(11):1534–1544
Kuberan B, Lech M, Zhang L, Wu ZL, Beeler DL, Rosenberg RD (2002) Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospry ionization time-of-flight mass spectrometry. J Am Chem Soc 124(29):8707–8718
Zaia J, Costello CE (2003) Tandem mass spectrometry of sulfated heparin-like glycosaminoglycan oligosaccharides. Anal Chem 75(10):2445–2455
Saad OM, Leary JA (2004) Delineating mechanisms of dissociation for isomeric heparin disaccharides using isotope labeling and ion trap tandem mass spectrometry. J Am Soc Mass Spectrom 15(9):1274–1286
Domon B, Costello CE (1988) Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. Biochemistry 27(5):1534–1543
Henriksen J, Ringborg LH, Roepstorff P (2004) On-line size-exclusion chromatography/mass spectrometry of low molecular mass heparin. J Mass Spectrom 39:1305–1312
Acknowledgments
This work was performed, and originally published while the authors were employees of Momenta Pharmaceuticals Inc.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Lech, M., Capila, I., Kaundinya, G.V. (2022). Mass Spectrometric Methods for the Analysis of Heparin and Heparan Sulfate. In: Balagurunathan, K., Nakato, H., Desai, U., Saijoh, Y. (eds) Glycosaminoglycans. Methods in Molecular Biology, vol 2303. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1398-6_19
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1398-6_19
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1397-9
Online ISBN: 978-1-0716-1398-6
eBook Packages: Springer Protocols